Perfil de la empresa · Healthcare

Apeloa Pharmaceutical Co Ltd

000739 · Shenzhen
País / Región
China
Fecha de salida a bolsa
9 de mayo de 1997
Empleados
6787
Buffett Score
71/100
Sólida
Capitalización32,14 mil M CNY
Ingresos (TTM)9162,42 M CNY
EBITDA1598,19 M CNY
Margen neto9,28 %
ROE12,75 %
PER (TTM)37,49
PER previsto0
PEG0
BPA0,74 CNY
Rentabilidad por dividendo1,42 %
Rango de 52 semanas14,70 CNY – 27,89 CNY

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People's Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects; pharmaceutical business includes anti-infective, cardiovascular, psychotropic, hepatobiliary and anti-tumor categories. The company also provides technology platforms, such as flow chemistry, synthetic biology and biocatalysis, crystallization and particle engineering, peptide, high potency compound, conjugate library service, oligonucleotide synthesis, and preparation and purification; and controlled-release formulation development, taste masking technology, and particle flow simulation. In addition, it exports its products under the Tianliwei, Baishixin, Li'an, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People's Republic of China.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.

Aún no hay análisis sobre este valor en tu idioma.